| Name | transmembrane protein 268 |
| Description | Predicted to be located in plasma membrane. [provided by Alliance of Genome Resources, Mar 2025] |
| Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nThe transmembrane protein 268 (TMEM268) is a novel regulator implicated in maintaining integrin β4 (ITGB4) homeostasis. Research has demonstrated that deletion of TMEM268 in gastric cancer cells diminishes cell viability, proliferation, and adhesion, induces S‐phase cell cycle arrest, and disrupts cytoskeletal remodeling. Mechanistically, TMEM268 interacts via its C-terminal domain with ITGB4, and its absence accelerates ITGB4 ubiquitin‐mediated degradation. This destabilization leads to a disassociation of the ITGB4/PLEC complex, ultimately impairing cytoskeletal integrity and suppressing both primary tumor growth and metastasis in vivo."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}]}, {"type": "t", "text": ""}, {"type": "p", "children": [{"type": "t", "text": "\nIn contrast, other studies of uncharacterized proteins in muscle tissues highlight distinct mechanisms of cellular regulation. For example, the cardiac‐enriched FHL2-interacting protein (CEFIP) localizes to the sarcomeric z-disc and modulates hypertrophic signaling via enhancement of the calcineurin/NFAT pathway in cardiomyocytes, contributing to cardiac remodeling and disease pathogenesis."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "2"}]}, {"type": "t", "text": ""}, {"type": "p", "children": [{"type": "t", "text": "\nSimilarly, genetic investigations in dilated cardiomyopathy have identified C10orf71 as an intrinsically disordered protein critical for proper cardiac contractility, with its loss leading to abnormal heart development and dysfunction. Although these proteins operate in cardiac contexts and through divergent mechanisms, their discovery underscores the broader significance of previously uncharacterized proteins in regulating cellular architecture and signaling. In this landscape, TMEM268’s unique role in sustaining ITGB4 levels and cytoskeletal organization in gastric cancer cells represents a distinct mechanistic pathway with promising therapeutic implications."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "3"}]}]}]}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Dubeiqi Hong, Xuan Zhang, Riyong Li, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Deletion of TMEM268 inhibits growth of gastric cancer cells by downregulating the ITGB4 signaling pathway."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Death Differ (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41418-018-0223-3"}], "href": "https://doi.org/10.1038/s41418-018-0223-3"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30361615"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30361615"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Franziska Dierck, Christian Kuhn, Claudia Rohr, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The novel cardiac z-disc protein CEFIP regulates cardiomyocyte hypertrophy by modulating calcineurin signaling."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M117.786764"}], "href": "https://doi.org/10.1074/jbc.M117.786764"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28717008"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28717008"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Yang Li, Ke Ma, Zhujun Dong, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Frameshift variants in C10orf71 cause dilated cardiomyopathy in human, mouse, and organoid models."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Clin Invest (2024)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1172/JCI177172"}], "href": "https://doi.org/10.1172/JCI177172"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "38950288"}], "href": "https://pubmed.ncbi.nlm.nih.gov/38950288"}]}]}]}
|
| NCBI Gene ID | 203197 |
| API | |
| Download Associations | |
| Predicted Functions |
![]() |
| Co-expressed Genes |
![]() |
| Expression in Tissues and Cell Lines |
![]() |
TMEM268 has 1,834 functional associations with biological entities spanning 6 categories (chemical, functional term, phrase or reference, disease, phenotype or trait, cell line, cell type or tissue, gene, protein or microRNA, sequence feature) extracted from 24 datasets.
Click the + buttons to view associations for TMEM268 from the datasets below.
If available, associations are ranked by standardized value
| Dataset | Summary | |
|---|---|---|
| Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of TMEM268 gene relative to other tissue samples from the Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles dataset. | |
| Carcinogenome Chemical Perturbation Carcinogenicity Signatures | small molecule perturbations changing expression of TMEM268 gene from the Carcinogenome Chemical Perturbation Carcinogenicity Signatures dataset. | |
| CellMarker Gene-Cell Type Associations | cell types associated with TMEM268 gene from the CellMarker Gene-Cell Type Associations dataset. | |
| CM4AI KOLF21J CRISPRi Gene Perturbation Atlas | gene perturbations changing expression of TMEM268 gene from the CM4AI KOLF21J CRISPRi Gene Perturbation Atlas dataset. | |
| COMPARTMENTS Experimental Protein Localization Evidence Scores 2025 | cellular components containing TMEM268 protein in low- or high-throughput protein localization assays from the COMPARTMENTS Experimental Protein Localization Evidence Scores 2025 dataset. | |
| COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 | cellular components co-occuring with TMEM268 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 dataset. | |
| DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 | diseases co-occuring with TMEM268 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. | |
| GTEx eQTL 2025 | SNPs regulating expression of TMEM268 gene from the GTEx eQTL 2025 dataset. | |
| GTEx Tissue Gene Expression Profiles 2023 | tissues with high or low expression of TMEM268 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles 2023 dataset. | |
| GTEx Tissue-Specific Aging Signatures | tissue samples with high or low expression of TMEM268 gene relative to other tissue samples from the GTEx Tissue-Specific Aging Signatures dataset. | |
| GWAS Catalog SNP-Phenotype Associations 2025 | phenotypes associated with TMEM268 gene in GWAS datasets from the GWAS Catalog SNP-Phenotype Associations 2025 dataset. | |
| JASPAR Predicted Human Transcription Factor Targets 2025 | transcription factors regulating expression of TMEM268 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Human Transcription Factor Targets dataset. | |
| JASPAR Predicted Mouse Transcription Factor Targets 2025 | transcription factors regulating expression of TMEM268 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Mouse Transcription Factor Targets 2025 dataset. | |
| LINCS L1000 CMAP Chemical Perturbation Consensus Signatures | small molecule perturbations changing expression of TMEM268 gene from the LINCS L1000 CMAP Chemical Perturbations Consensus Signatures dataset. | |
| MoTrPAC Rat Endurance Exercise Training | tissue samples with high or low expression of TMEM268 gene relative to other tissue samples from the MoTrPAC Rat Endurance Exercise Training dataset. | |
| NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles | drug perturbations changing expression of TMEM268 gene from the NIBR DRUG-seq U2OS MoA Box dataset. | |
| Replogle et al., Cell, 2022 K562 Essential Perturb-seq Gene Perturbation Signatures | gene perturbations changing expression of TMEM268 gene from the Replogle et al., Cell, 2022 K562 Essential Perturb-seq Gene Perturbation Signatures dataset. | |
| Rummagene Transcription Factor Associations 2026 | transcription factors regulating expression of TMEM268 gene from the Rummagene Transcription Factor Associations 2026 dataset. | |
| RummaGEO Drug Perturbation Signatures | drug perturbations changing expression of TMEM268 gene from the RummaGEO Drug Perturbation Signatures dataset. | |
| RummaGEO Gene Perturbation Signatures | gene perturbations changing expression of TMEM268 gene from the RummaGEO Gene Perturbation Signatures dataset. | |
| Sci-Plex Drug Perturbation Signatures | drug perturbations changing expression of TMEM268 gene from the Sci-Plex Drug Perturbation Signatures dataset. | |
| TISSUES Curated Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of TMEM268 protein from the TISSUES Curated Tissue Protein Expression Evidence Scores 2025 dataset. | |
| TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of TMEM268 protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 dataset. | |
| TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 | tissues co-occuring with TMEM268 protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 dataset. | |